| __timestamp | Arrowhead Pharmaceuticals, Inc. | Zoetis Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 23138050 | 396000000 |
| Thursday, January 1, 2015 | 57410147 | 364000000 |
| Friday, January 1, 2016 | 41454452 | 376000000 |
| Sunday, January 1, 2017 | 31690298 | 382000000 |
| Monday, January 1, 2018 | 52968505 | 432000000 |
| Tuesday, January 1, 2019 | 81048686 | 457000000 |
| Wednesday, January 1, 2020 | 128874979 | 463000000 |
| Friday, January 1, 2021 | 206342000 | 508000000 |
| Saturday, January 1, 2022 | 297307000 | 539000000 |
| Sunday, January 1, 2023 | 353188000 | 614000000 |
| Monday, January 1, 2024 | 505870000 | 686000000 |
Unleashing insights
In the competitive landscape of pharmaceuticals, research and development (R&D) spending is a critical indicator of innovation and future growth. Over the past decade, Zoetis Inc. and Arrowhead Pharmaceuticals, Inc. have demonstrated contrasting trajectories in their R&D investments. From 2014 to 2023, Zoetis consistently increased its R&D budget, peaking at approximately 614 million in 2023, reflecting a robust 55% growth from 2014. In contrast, Arrowhead Pharmaceuticals exhibited a more dramatic rise, with R&D expenses surging by over 2,000% from 2014 to 2024, reaching around 506 million. This stark difference highlights Arrowhead's aggressive push towards innovation, potentially positioning it as a formidable player in the biotech sector. However, the data for Zoetis in 2024 remains unavailable, leaving room for speculation on its future strategy. As these companies continue to evolve, their R&D investments will be pivotal in shaping their competitive edge.
Research and Development Expenses Breakdown: Novo Nordisk A/S vs Arrowhead Pharmaceuticals, Inc.
Analyzing R&D Budgets: Zoetis Inc. vs Takeda Pharmaceutical Company Limited
R&D Insights: How Zoetis Inc. and Sarepta Therapeutics, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Halozyme Therapeutics, Inc.
Comparing Innovation Spending: Zoetis Inc. and Ultragenyx Pharmaceutical Inc.
Analyzing R&D Budgets: Zoetis Inc. vs Viking Therapeutics, Inc.
Zoetis Inc. vs ADMA Biologics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Zoetis Inc. and Travere Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Amphastar Pharmaceuticals, Inc.
Research and Development Investment: Alnylam Pharmaceuticals, Inc. vs Arrowhead Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Neurocrine Biosciences, Inc. and Arrowhead Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Bausch Health Companies Inc. and Arrowhead Pharmaceuticals, Inc.